GLOW Peptide Blend: GHK-Cu, BPC-157, TB-500 in One Vial
GLOW is a vendor blend, usually GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg. What each part does, the untested combination, quality data and protocols.
Peptide Therapy
Limited EvidenceBPC-157
Gastric pentadecapeptide studied mainly in animals; human data are a few very small studies. Evidence, safety and regulatory status.
01
02
KLOW Peptide Blend: GLOW Plus KPV, Never Tested Together
KLOW is a vendor blend of GHK-Cu 50 mg, BPC-157, TB-500 and KPV 10 mg each. Components, the missing combination data, lab-test results and protocols.
03
Tri-Heal Max Blend: TB-500, BPC-157 and KPV, Unstudied
Tri-Heal Max is a 45 mg vendor blend of TB-500 25 mg, BPC-157 10 mg and KPV 10 mg. What it contains, why protocols disagree, and what is unknown.
04
Peptide Cycling Protocols: How Long to Run Each Peptide and When to Take a Break
Evidence-based cycling schedules for BPC-157, TB-500, CJC-1295/Ipamorelin, Sermorelin, Epithalon, and Thymosin Alpha-1 — when to run, when to pause, and why it matters.
05
BPC-157 Contraindications: Who Should Not Use This Peptide
A clinical guide to BPC-157 contraindications, relative cautions, and drug interactions — covering cancer patients, transplant recipients, pregnancy, and autoimmune conditions.
06
FDA 2026 Peptide Compounding Update: What the Category Lists Say
What FDA's May 2026 503A category update actually changed for peptides: GHK-Cu, VIP, the withdrawn category 2 nominations, and what it means for US access.
07
Peptides for Autoimmune Disease: A Physician's Evidence-Based Guide
Discover how immunomodulatory peptides like Thymosin Alpha-1, BPC-157, and LL-37 can help regulate immune dysfunction in autoimmune conditions. Clinical protocols and evidence.
08
Peptide Stacking: A Physician's Guide to Combining BPC-157, TB-500, and GHK-Cu
Learn how to combine therapeutic peptides like BPC-157, TB-500, and GHK-Cu, with dosing protocols, the clinical evidence, and the safety questions.
09
Peptide Therapy Benefits: A Physician's Evidence-Based Overview
Dr. Douwes reviews the clinically relevant benefits of peptide therapy — from tissue repair and immune modulation to longevity and brain health. What evidence supports each claim.
10
Best Peptides for Healing: A Physician's Ranked Guide to Tissue Repair
Dr. med. univ. Julian Douwes ranks the most effective peptides for tissue repair, wound healing, and recovery — with dosing context and evidence grades for each.
11
BPC-157 Oral vs Injection: Which Route Delivers Better Results?
Physician comparison of BPC-157 oral capsules versus subcutaneous injection — covering bioavailability, onset, dosing, and clinical use cases for each route.
12
Peptide Therapy for Women: What the Clinical Evidence Actually Shows
A physician's evidence-based guide to peptide therapy for women — covering hormonal interactions, key peptides, dosing considerations, and who is a suitable candidate.
13
BPC-157 Side Effects: What the Evidence Actually Shows
Honest assessment of BPC-157 side effects, safety data, FDA warnings, and theoretical risks. What we know, what we don't, and what to watch for.
14
BPC-157 Dosage Guide: Subcutaneous, Oral, and Injection Protocols
Evidence-based BPC-157 dosing protocols. Subcutaneous vs oral routes, loading vs maintenance, body weight calculations, and clinical observations.
15
BPC-157 vs TB-500: Which Peptide for Tissue Repair?
A clinical comparison of BPC-157 and TB-500 for tissue repair. Mechanisms, evidence quality, best use cases, combination protocols, and what is seen in practice.
16
BPC-157: What the Research Actually Shows
Honest physician's assessment of BPC-157 peptide. Mechanisms, animal vs human evidence, dosing, safety, and clinical observations from Dr. med. univ. Julian Douwes.
